![Andrew Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Parker
Vorstandsvorsitzender bei
ArisGen SA
Profil
Andrew Parker is currently the Chief Executive Officer of ArisGen SA and the Chief Executive Officer & Member-Supervisory Board of Step Pharma SAS. Previously, he worked as the General Partner & Scientific Director of Eclosion2 SA, Independent Director of GeNeuro SA (Switzerland), Scientific Director & General Partner of Eclosion2 & Cie Scpc, Principal at AstraZeneca PLC and Beerse Betonhandel, Vice President & Head-Exploratory Projects at Shire Plc, Chief Science Officer & Executive Vice President at Zealand Pharma A, Principal at Janssen Pharmaceutica NV, and Vice President-Pre Clinical Research at Opsona Therapeutics Ltd. Dr. Parker holds an MBA from Warwick Business School and a doctorate from The National Institute For Medical Research.
Aktive Positionen von Andrew Parker
| Unternehmen | Position | Beginn |
|---|---|---|
ArisGen SA
 ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Vorstandsvorsitzender | - |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Vorstandsvorsitzender | 05.09.2019 |
Ehemalige bekannte Positionen von Andrew Parker
| Unternehmen | Position | Ende |
|---|---|---|
| ZEALAND PHARMA A/S | Technik-/Wissenschafts-/F&E-Leiter | 31.08.2019 |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| GENEURO SA | Direktor/Vorstandsmitglied | - |
Ausbildung von Andrew Parker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Beerse Betonhandel
 Beerse Betonhandel Regional BanksFinance Functions Related To Depository Banking Not Elsewhere Classified | Finance |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
The National Institute For Medical Research
 The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Finance |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Health Technology |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
Eclosion2 & Cie Scpc | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
